Figure 5. Changes in biochemical markers in all patients with inflammatory bowel disease.
hs‐CRP indicates high‐sensitivity C‐reactive protein; IL‐6, interleukin‐6; and TNF‐α, tumor necrosis factor‐α.
hs‐CRP indicates high‐sensitivity C‐reactive protein; IL‐6, interleukin‐6; and TNF‐α, tumor necrosis factor‐α.